Early Clinical and Hemodynamic Outcomes After Stented and Stentless Aortic Valve Replacement: Results From a Randomized Controlled Trial Ayyaz Ali, MRCS, James C. Halstead, MRCS, Fay Cafferty, MS, Linda Sharples, PhD, Fiona Rose, BA, Evelyn Lee, FRCP, Rosemary Rusk, MRCP, John Dunning, FRCS, Vincenzo Argano, FRCS, Steven Tsui, MD, FRCS The Annals of Thoracic Surgery Volume 83, Issue 6, Pages 2162-2168 (June 2007) DOI: 10.1016/j.athoracsur.2007.01.021 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Trial conduct. The Annals of Thoracic Surgery 2007 83, 2162-2168DOI: (10.1016/j.athoracsur.2007.01.021) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Mean systolic transvalvular gradient (95% confidence intervals). (AVR = aortic valve replacement.) The Annals of Thoracic Surgery 2007 83, 2162-2168DOI: (10.1016/j.athoracsur.2007.01.021) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Effective orifice area (95% confidence intervals). (AVR = aortic valve replacement.) The Annals of Thoracic Surgery 2007 83, 2162-2168DOI: (10.1016/j.athoracsur.2007.01.021) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Left ventricular (LV) mass (95% confidence intervals). (Significant reduction in LV mass from preoperative to eight weeks in both groups. Stented, p < 0.001; stentless, p < 0.001; AVR = aortic valve replacement.) The Annals of Thoracic Surgery 2007 83, 2162-2168DOI: (10.1016/j.athoracsur.2007.01.021) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions